search icon

    Market Snapshot

    • S&P Futures

      3,814.5

    • Dow Futures

      30,961

    • Nasdaq Futures

      11,557.75

    blog search icon

    Allakos Inc.

    (NASDAQ:ALLK)

    $3.02

    $-0.11

    -3.51%

    Allakos Inc. Chart

    ALLK Stock Price Today

    Allakos Inc. (ALLK) stock declined over -3.51% intraday to trade at $3.02 a share on NASDAQ. The stock opened with a loss of -6.50% at $3.16 and touched an intraday high of $3.23, falling -3.51% against the last close of $3.13. The stock went to a low of $2.92 during the session.

    Stock Snapshot

    $3.13

    Prev. Close

    171.51 Million

    Market Cap

    $2.92

    Day Low

    $3.16

    Open

    54.69 Million

    Number of Shares

    $3.23

    Day High

    -

    P/E ratio

    -7.56

    EPS (TTM)

    7.76

    Cash Flow per Share

    8.44

    Free Float in %

    9.66

    Book Value

    646,449

    Volume

    Allakos Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$3.16$3.23$2.92$3.02649,900
    2022-06-30$3.23$3.3$3.12$3.13399,600
    2022-06-29$3.2$3.4$3.19$3.32583,100
    2022-06-28$3.33$3.36$3.12$3.23796,900
    2022-06-27$3.44$3.48$3.21$3.34937,100
    2022-06-24$3.53$3.67$3.42$3.435,167,400
    2022-06-23$3.29$3.52$3.21$3.49782,900
    2022-06-22$3.05$3.46$3$3.271,316,400
    2022-06-21$3.02$3.2$2.97$3.091,086,100
    2022-06-17$2.61$3.15$2.59$2.972,512,800

    Contact Details

    975 Island Drive
    Suite 201
    Redwood City, CA 94065
    United States

    Webiste:ALLK

    650 597 5002

    Company Information

    Employees-

    Beta0.86

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Allakos Inc. operates as a clinical stage biopharmaceutical company. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic esophagitis. The is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria, and indolent systemic mastocytosis. Allakos Inc. was incorporated in 2012 and is headquartered in Redwood City, California.

    Frequently Asked Questions

    icon

    What is the current Allakos Inc. (ALLK) stock price?

    Allakos Inc. (NASDAQ: ALLK) stock price is $3.02 as of the last check on Friday, July 1. During the trading session, ALLK stock reached the peak price of $3.23 while $2.92 was the lowest point it dropped to.

    icon

    ALLK's industry and sector of operation?

    The NASDAQ listed ALLK is part of Biotechnology industry that operates in the broader Health Care sector. Allakos Inc. operates as a clinical stage biopharmaceutical company.

    icon

    Who are the executives of ALLK?

    Mr. Mark Asbury
    Chief Legal Officer & Gen. Counsel
    Mr. Tim Varacek
    Chief Commercial Officer
    Mr. Alan Chang
    Director of Medical Affairs & Data Analytics
    Dr. Robert Alexander Ph.D.
    CEO & Director

    icon

    What is the ALLK stock price today?

    ALLK stock traded closed the last session at $3.02, which is $-0.11 or -3.51% lower than its previous close of $3.13. ALLK's current trading price is 19.13% lower than its 52-week high of $112.87 where as its distance from 52-week low of 2.54% is -97.32%.

    icon

    How many employees does ALLK have?

    Number of ALLK employees currently stands at -. ALLK operates from 975 Island Drive, Suite 201, Redwood City, CA 94065, United States.

    icon

    Link for ALLK official website?

    Official Webiste of $ALLK is: https://www.allakos.com

    icon

    How do I contact ALLK?

    ALLK could be contacted at ALLK operates from 975 Island Drive, Suite 201, Redwood City, CA 94065, United States, or at phone #650 597 5002 and can also be accessed through its website.

    icon

    How many shares of ALLK are traded daily?

    ALLK stock volume for the day was 646,449 shares while in the previous session number of ALLK shares traded was 649,900 . The average number of ALLK shares traded daily for last 3 months was 1 Million.

    icon

    How much did ALLK change today?

    The percentage change in ALLK stock occurred in the recent session was -3.51% while the dollar amount for the price change in ALLK stock was $-0.11.

    icon

    What price range ALLK stock been trading in?

    In the recent session, the day high for ALLK stock was $3.23 while the low for ALLK stock touched on the day was $2.92.

    icon

    What is the market cap of ALLK currently?

    The market value of ALLK currently stands at 171.51 Million with its latest stock price at $3.02 and 54.69 Million of its shares outstanding.